TY - JOUR
T1 - Attributable risk fraction of prehypertension on cardiovascular disease mortality in the Japanese population
T2 - The Ohsaki study
AU - Hozawa, Atsushi
AU - Kuriyama, Shinichi
AU - Kakizaki, Masako
AU - Ohmori-Matsuda, Kaori
AU - Ohkubo, Takayoshi
AU - Tsuji, Ichiro
N1 - Funding Information:
acknowledgment:We thankYoshiko Nakata, MikaWagatsuma, and hiroko Okajima from the Division of Epidemiology, Department of Public health and Forensic Medicine,Tohoku University Graduate School of Medicine, Sendai, Japan, for their research assistance.This study was supported by a health Sciences Research Grant for health Services (h19-Seisaku-Ippan-026, h20-Junkankitou (Seisyu)-Ippan-013), Ministry of health, Labour and Welfare, Japan.
PY - 2009/3
Y1 - 2009/3
N2 - Background: Although relative risk of prehypertension (pre-HT) on cardiovascular disease (CVD) mortality is modest, prevalence of pre-HT is large, that is, population attributable fraction (PAF) of pre-HT on CVD mortality might be large. However, no studies have reported the fraction. Methods: We followed 12,928 Japanese National Health Insurance (NHI) beneficiaries aged 40-79 years without a history of CVD. On the basis of their blood pressure (BP), the participants were categorized as normal BP, pre-HT, and hypertension (HT) (Seventh Report of the Joint National Committee criteria). Multivariate-adjusted Cox proportional hazards model was used to estimate the hazard ratio (HR) of the BP status vs. CVD mortality. Results: During 12-years of follow-up, 321 participants died of CVD. As positive relation between BP category and CVD mortality was steeper in middle-aged (40-64 years) than that in elderly (65-79 years), we separately calculated PAF on CVD mortality among middle-aged and elderly. HR (95% confidence interval) for cardiovascular mortality for pre-HT and HT, respectively, was 1.31 (0.59-2.94) and 2.98 (1.39-6.41) in middle-aged, and 1.03 (0.62-1.70) and 1.65 (1.02-2.64) in elderly. Non-normal BP, i.e., pre-HT and HT, accounted for 47 and 26% of the CVD deaths among the middle-aged and elderly participants, respectively. Although the PAF of pre-HT was larger in the middle-aged participants (7%) than that in the elderly ones (0%), neither fraction was considered large. Conclusion: The PAF on CVD mortality in pre-HT was not large compared with that in HT.
AB - Background: Although relative risk of prehypertension (pre-HT) on cardiovascular disease (CVD) mortality is modest, prevalence of pre-HT is large, that is, population attributable fraction (PAF) of pre-HT on CVD mortality might be large. However, no studies have reported the fraction. Methods: We followed 12,928 Japanese National Health Insurance (NHI) beneficiaries aged 40-79 years without a history of CVD. On the basis of their blood pressure (BP), the participants were categorized as normal BP, pre-HT, and hypertension (HT) (Seventh Report of the Joint National Committee criteria). Multivariate-adjusted Cox proportional hazards model was used to estimate the hazard ratio (HR) of the BP status vs. CVD mortality. Results: During 12-years of follow-up, 321 participants died of CVD. As positive relation between BP category and CVD mortality was steeper in middle-aged (40-64 years) than that in elderly (65-79 years), we separately calculated PAF on CVD mortality among middle-aged and elderly. HR (95% confidence interval) for cardiovascular mortality for pre-HT and HT, respectively, was 1.31 (0.59-2.94) and 2.98 (1.39-6.41) in middle-aged, and 1.03 (0.62-1.70) and 1.65 (1.02-2.64) in elderly. Non-normal BP, i.e., pre-HT and HT, accounted for 47 and 26% of the CVD deaths among the middle-aged and elderly participants, respectively. Although the PAF of pre-HT was larger in the middle-aged participants (7%) than that in the elderly ones (0%), neither fraction was considered large. Conclusion: The PAF on CVD mortality in pre-HT was not large compared with that in HT.
UR - http://www.scopus.com/inward/record.url?scp=60549103345&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=60549103345&partnerID=8YFLogxK
U2 - 10.1038/ajh.2008.335
DO - 10.1038/ajh.2008.335
M3 - Article
C2 - 19039309
AN - SCOPUS:60549103345
SN - 0895-7061
VL - 22
SP - 267
EP - 272
JO - American Journal of Hypertension
JF - American Journal of Hypertension
IS - 3
ER -